Neolixir Limited

Australia

Back to Profile

1-8 of 8 for Neolixir Limited Sort by
Query
Aggregations
IP Type
        Trademark 6
        Patent 2
Jurisdiction
        World 3
        United States 3
        Canada 2
Date
2025 2
2024 6
IPC Class
A61K 31/19 - Carboxylic acids, e.g. valproic acid 2
A61P 31/04 - Antibacterial agents 2
A01N 37/02 - Saturated carboxylic acids or thio-analogues thereofDerivatives thereof 1
A01N 37/36 - Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing at least one carboxylic group or a thio-analogue, or a derivative thereof, and a singly bound oxygen or sulfur atom attached to the same carbon skeleton, this oxygen or sulfur atom not being a member of a carboxylic group or of a thio-analogue, or of a derivative thereof, e.g. hydroxy-carboxylic acids 1
A01P 1/00 - DisinfectantsAntimicrobial compounds or mixtures thereof 1
See more
NICE Class
03 - Cosmetics and toiletries; cleaning, bleaching, polishing and abrasive preparations 6
05 - Pharmaceutical, veterinary and sanitary products 6
31 - Agricultural products; live animals 6
01 - Chemical and biological materials for industrial, scientific and agricultural use 2
Status
Pending 5
Registered / In Force 3

1.

LiXA

      
Application Number 1845389
Status Registered
Filing Date 2024-10-25
Registration Date 2024-10-25
Owner Neolixir Limited (Australia)
NICE Classes  ?
  • 03 - Cosmetics and toiletries; cleaning, bleaching, polishing and abrasive preparations
  • 05 - Pharmaceutical, veterinary and sanitary products
  • 31 - Agricultural products; live animals

Goods & Services

Cosmetics. Pharmaceutical and veterinary products to maintain or enhance health or treat disease; antibiotics; pharmaceutical and veterinary products to prevent or treat infectious disease, autoimmune disease, inflammatory disease and other immune disorders; antibiotic adjuvants; Pharmaceutical and veterinary products, ingredients and preparations, namely, pharmaceutical products and preparations for the impairment and prevention of infection, including planktonic and microbial biofilm colonies, the reversal of microbial resistance, the potentiation of antimicrobial agents, endotoxicity protection, anti-inflammatory and immune system enhancement; pharmaceutical and nutraceutical products for enhancing microbiome health; extracellular matrix and extracellular polymeric substances including polysaccharides, monosaccharides, exopolysaccharides, and proteins being dietary supplements; antimicrobial biocide, antibiotic, bactericidal agents, bacteriostatic agents; antimicrobial resistance breakers; human and animal antimicrobial treatments; pharmaceutical and veterinary products and preparations to prevent or mitigate bacterial biofilms and infections; cleaning agents and disinfectants for medical purposes, cleaning agents and disinfectants for hygiene purposes, cleaning agents and disinfectants for veterinary purposes, antimicrobial cleaning agents and disinfectants. Animal feed.

2.

LIXA

      
Application Number 1843907
Status Registered
Filing Date 2024-10-25
Registration Date 2024-10-25
Owner Neolixir Limited (Australia)
NICE Classes  ?
  • 03 - Cosmetics and toiletries; cleaning, bleaching, polishing and abrasive preparations
  • 05 - Pharmaceutical, veterinary and sanitary products
  • 31 - Agricultural products; live animals

Goods & Services

Cosmetics. Pharmaceutical and veterinary products to maintain or enhance health or treat disease; antibiotics; surfactants; pharmaceutical and veterinary products to prevent or treat infectious disease, autoimmune disease, inflammatory disease and other immune disorders; antibiotic adjuvants; Pharmaceutical and veterinary products, ingredients and preparations, namely, pharmaceutical products and preparations for the impairment and prevention of infection, including planktonic and microbial biofilm colonies, the reversal of microbial resistance, the potentiation of antimicrobial agents, endotoxicity protection, anti-inflammatory and immune system enhancement; pharmaceutical and nutraceutical products for enhancing microbiome health; extracellular matrix and extracellular polymeric substances including polysaccharides, monosaccharides, exopolysaccharides, and proteins for medical purposes; antimicrobial biocide, antibiotic, bactericidal agents, bacteriostatic agents; antibiotic resistance breakers; human and animal antimicrobial treatments; pharmaceutical and veterinary products and preparations to prevent or mitigate bacterial biofilms and infections; cleaning agents and disinfectants for medical purposes, cleaning agents and disinfectants for hygiene purposes, cleaning agents and disinfectants for veterinary purposes, antimicrobial cleaning agents and disinfectants. Animal feed.

3.

METHODS FOR BIOFILM DISRUPTION

      
Application Number 18693998
Status Pending
Filing Date 2022-11-11
First Publication Date 2024-12-05
Owner Neolixir Limited (Australia)
Inventor
  • Fonceca, Angela
  • Ditcham, Will
  • Flematti, Gavin
  • Everard, Mark
  • Barker, Andrew

Abstract

A composition for disrupting a biofilm, said composition comprising a 2-hydroxy carboxylic acid.

IPC Classes  ?

  • A01N 37/36 - Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing at least one carboxylic group or a thio-analogue, or a derivative thereof, and a singly bound oxygen or sulfur atom attached to the same carbon skeleton, this oxygen or sulfur atom not being a member of a carboxylic group or of a thio-analogue, or of a derivative thereof, e.g. hydroxy-carboxylic acids
  • A01P 1/00 - DisinfectantsAntimicrobial compounds or mixtures thereof
  • A61K 31/19 - Carboxylic acids, e.g. valproic acid
  • A61P 31/04 - Antibacterial agents

4.

DYSREGULATION OF PLANKTONIC BACTERIAL METABOLISM

      
Application Number AU2024050455
Publication Number 2024/229525
Status In Force
Filing Date 2024-05-09
Publication Date 2024-11-14
Owner NEOLIXIR LIMITED (Australia)
Inventor
  • Barker, Andrew
  • Eijkenboom, Maud
  • Haese, Ethan Clark
  • Green, Kathryn
  • Abberton, Catherine

Abstract

A composition comprising a 2-hydroxycarboxylic acid for dysregulating the metabolism of planktonic bacteria, and uses of the same.

IPC Classes  ?

  • A61K 31/19 - Carboxylic acids, e.g. valproic acid
  • A01N 37/02 - Saturated carboxylic acids or thio-analogues thereofDerivatives thereof
  • A61K 31/407 - Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with heterocyclic ring systems, e.g. ketorolac, physostigmine
  • A61K 31/427 - Thiazoles not condensed and containing further heterocyclic rings
  • A61K 31/43 - Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula , e.g. penicillins, penems
  • A61K 31/496 - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
  • A61K 31/53 - Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
  • A61K 31/65 - Tetracyclines
  • A61K 33/30 - ZincCompounds thereof
  • A61K 33/34 - CopperCompounds thereof
  • A61K 38/12 - Cyclic peptides
  • A61K 38/14 - Peptides containing saccharide radicalsDerivatives thereof
  • A61L 2/18 - Liquid substances
  • A61L 101/36 - Carboxylic acids or derivatives thereof
  • A61P 31/04 - Antibacterial agents

5.

LIXA

      
Application Number 238553500
Status Pending
Filing Date 2024-10-25
Owner Neolixir Limited (Australia)
NICE Classes  ?
  • 03 - Cosmetics and toiletries; cleaning, bleaching, polishing and abrasive preparations
  • 05 - Pharmaceutical, veterinary and sanitary products
  • 31 - Agricultural products; live animals

Goods & Services

(1) Cosmetics. (2) Pharmaceutical and veterinary products to maintain or enhance health or treat disease; antibiotics; surfactants; pharmaceutical and veterinary products to prevent or treat infectious disease, autoimmune disease, inflammatory disease and other immune disorders; antibiotic adjuvants; Pharmaceutical and veterinary products, ingredients and preparations, namely, pharmaceutical products and preparations for the impairment and prevention of infection, including planktonic and microbial biofilm colonies, the reversal of microbial resistance, the potentiation of antimicrobial agents, endotoxicity protection, anti-inflammatory and immune system enhancement; pharmaceutical and nutraceutical products for enhancing microbiome health; extracellular matrix and extracellular polymeric substances including polysaccharides, monosaccharides, exopolysaccharides, and proteins for medical purposes; antimicrobial biocide, antibiotic, bactericidal agents, bacteriostatic agents; antibiotic resistance breakers; human and animal antimicrobial treatments; pharmaceutical and veterinary products and preparations to prevent or mitigate bacterial biofilms and infections; cleaning agents and disinfectants for medical purposes, cleaning agents and disinfectants for hygiene purposes, cleaning agents and disinfectants for veterinary purposes, antimicrobial cleaning agents and disinfectants. (3) Animal feed.

6.

LIXA

      
Application Number 238691000
Status Pending
Filing Date 2024-10-25
Owner Neolixir Limited (Australia)
NICE Classes  ?
  • 03 - Cosmetics and toiletries; cleaning, bleaching, polishing and abrasive preparations
  • 05 - Pharmaceutical, veterinary and sanitary products
  • 31 - Agricultural products; live animals

Goods & Services

(1) Cosmetics. (2) Pharmaceutical and veterinary products to maintain or enhance health or treat disease; antibiotics; pharmaceutical and veterinary products to prevent or treat infectious disease, autoimmune disease, inflammatory disease and other immune disorders; antibiotic adjuvants; Pharmaceutical and veterinary products, ingredients and preparations, namely, pharmaceutical products and preparations for the impairment and prevention of infection, including planktonic and microbial biofilm colonies, the reversal of microbial resistance, the potentiation of antimicrobial agents, endotoxicity protection, anti-inflammatory and immune system enhancement; pharmaceutical and nutraceutical products for enhancing microbiome health; extracellular matrix and extracellular polymeric substances including polysaccharides, monosaccharides, exopolysaccharides, and proteins being dietary supplements; antimicrobial biocide, antibiotic, bactericidal agents, bacteriostatic agents; antimicrobial resistance breakers; human and animal antimicrobial treatments; pharmaceutical and veterinary products and preparations to prevent or mitigate bacterial biofilms and infections; cleaning agents and disinfectants for medical purposes, cleaning agents and disinfectants for hygiene purposes, cleaning agents and disinfectants for veterinary purposes, antimicrobial cleaning agents and disinfectants. (3) Animal feed.

7.

LIXA

      
Serial Number 98792313
Status Pending
Filing Date 2024-10-09
Owner Neolixir Limited (Australia)
NICE Classes  ?
  • 01 - Chemical and biological materials for industrial, scientific and agricultural use
  • 03 - Cosmetics and toiletries; cleaning, bleaching, polishing and abrasive preparations
  • 05 - Pharmaceutical, veterinary and sanitary products
  • 31 - Agricultural products; live animals

Goods & Services

Surfactants for use in connection with agricultural pesticides; extracellular matrix and extracellular polymeric substances namely polysaccharides, monosaccharides, exopolysaccharides, and proteins for use in the manufacture of agricultural pesticides, animal feed, veterinary products, cleaning agents and surface hygiene products Cosmetics; cleaning agents for medical purposes, cleaning agents for hygiene purposes, cleaning agents for veterinary purposes, antimicrobial cleaning agents Pharmaceutical products to maintain or enhance health or treat disease, namely infectious disease, autoimmune disease, inflammatory disease and other immune disorders ; veterinary products, namely pharmaceuticals, nutritional supplements, complementary health products, anti-infectives and anti-inflammatories; antibiotics; pharmaceutical products to prevent or treat infectious disease, autoimmune disease, inflammatory disease and other immune disorders; veterinary vaccines for livestock and companion animals for treating infectious disease, autoimmune disease, inflammatory disease and other immune disorders; antibiotic adjuvants; Pharmaceutical products, ingredients and preparations, namely, pharmaceutical preparations for the impairment and prevention of infection, namely planktonic and microbial biofilm colonies, the reversal of microbial resistance, the potentiation of antimicrobial agents, endotoxicity protection, anti-inflammatory and immune system enhancement; products which enhance the health of microbiomes, namely dietary supplements, gut health supportive treatments and products, functional foods; antimicrobial biocide, antibiotic, bactericidal agents, bacteriostatic agents for use in pharmaceuticals, medical materials such as wound dressings, sanitary preparations and animal health products; resistance breakers, namely, pharmaceuticals, medical materials, sanitary preparations and veterinary products; human and animal antimicrobial treatments, namely, antibiotics and pharmaceuticals to be administered alongside, or instead of, antibiotics; pharmaceutical preparations to prevent or mitigate bacterial biofilms and infections; disinfectants for medical purposes, disinfectants for hygiene purposes, disinfectants for veterinary purposes, antimicrobial disinfectants Animal feed

8.

LIXA

      
Serial Number 98792320
Status Pending
Filing Date 2024-10-09
Owner Neolixir Limited (Australia)
NICE Classes  ?
  • 01 - Chemical and biological materials for industrial, scientific and agricultural use
  • 03 - Cosmetics and toiletries; cleaning, bleaching, polishing and abrasive preparations
  • 05 - Pharmaceutical, veterinary and sanitary products
  • 31 - Agricultural products; live animals

Goods & Services

Surfactants for use in connection with agricultural pesticides; extracellular matrix and extracellular polymeric substances namely polysaccharides, monosaccharides, exopolysaccharides, and proteins for use in the manufacture of agricultural pesticides, animal feed, veterinary products, cleaning agents and surface hygiene products Cosmetics; cleaning agents for medical purposes, cleaning agents for hygiene purposes, cleaning agents for veterinary purposes, antimicrobial cleaning agents Pharmaceutical products to maintain or enhance health or treat disease, namely infectious disease, autoimmune disease, inflammatory disease and other immune disorders ; veterinary products, namely pharmaceuticals, nutritional supplements, complementary health products, anti-infectives and anti-inflammatories; antibiotics; pharmaceutical products to prevent or treat infectious disease, autoimmune disease, inflammatory disease and other immune disorders; veterinary vaccines for livestock and companion animals for treating infectious disease, autoimmune disease, inflammatory disease and other immune disorders; antibiotic adjuvants; Pharmaceutical products, ingredients and preparations, namely, pharmaceutical preparations for the impairment and prevention of infection, namely planktonic and microbial biofilm colonies, the reversal of microbial resistance, the potentiation of antimicrobial agents, endotoxicity protection, anti-inflammatory and immune system enhancement; products which enhance the health of microbiomes, namely dietary supplements, gut health supportive treatments and products, functional foods; antimicrobial biocide, antibiotic, bactericidal agents, bacteriostatic agents for use in pharmaceuticals, medical materials such as wound dressings, sanitary preparations and animal health products; resistance breakers, namely, pharmaceuticals, medical materials, sanitary preparations and veterinary products; human and animal antimicrobial treatments, namely, antibiotics and pharmaceuticals to be administered alongside, or instead of, antibiotics; pharmaceutical preparations to prevent or mitigate bacterial biofilms and infections; disinfectants for medical purposes, disinfectants for hygiene purposes, disinfectants for veterinary purposes, antimicrobial disinfectants Animal feed